From designing molecules to making medicines: AI drug discovery enters its next phase
AI is moving from lab novelty to clinical reality. The next test is whether faster molecule…
Biotech startup METiS Therapeutics plans Hong Kong IPO with AI-driven drug delivery revolution
By Da Cheung METiS Therapeutics, a drug discovery and delivery biotech, has received the regulatory green light…
Latest
- Enflame IPO adds to Shanghai’s AI chip boom
- China’s open-source LLMs are looking for new ways to make money overseas
- Apple joins the foldable phone fight. Can the industry justify the price?
- Alibaba’s ‘internet barnacles’ face a reckoning as big-tech managers lose their shine
- Orbiting the future: China’s 3D vision star Orbbec sets its sights on Hong Kong listing
